Reparenco has obtained strategic advice in preparation for its sale to Smurfit Kappa
Reparenco's supervisory board has obtained strategic advice on the envisaged sale of assets to Smurfit Kappa Group plc.
Reparenco is a Netherlands-based paper and recycling business that operates a two-machine paper mill with a capacity of 675,000 tonnes together with a 750,000 tonne recovered fiber operation.
Smurfit Kappa Group is one of the world's largest integrated manufacturers of paper-based packaging products, with approximately 370 operations in Europe and the Americas. It has around 43,000 employees across 35 countries and sales of US$10 billion in 2017. The company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Reparenco is owned by H2 Equity Partners, an independent private equity firm active in the Benelux, Germany and the UK.
Oaklins' Dutch team provided the strategic advice in preparation for the sale.
Falar com a equipa da transação
Jonathan I. Mishkin
Oaklins TM Capital
Transações relacionadas
Hemink Groep has been acquired by Gimv
Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.
Saber maisOGD has been sold to Building Beyond Technology Group
Building Beyond Technology Group (BBTG) strengthens its position in the IT sector by welcoming OGD IT-Dienstverlening (OGD) to its platform. With over 1,400 employees, OGD is an established name in the Dutch market as a mission-critical IT service provider for large-scale clients. This addition not only increases BBTG’s scale but also enhances its domain expertise and execution capabilities through close cooperation with the other platform companies.
Saber maisThe Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Saber mais